---
provider: openscientist
model: openscientist-autonomous
cached: false
start_time: '2026-10-15T01:37:37.212109'
end_time: '2026-10-15T02:40:49.027035'
duration_seconds: 3791.81
template_file: templates/treegrafter_function_hypothesis.md
template_variables:
  organism: OCTVU
  gene: DDO
  gene_symbol: DDO
  uniprot_accession: A0A7E6FSU6
  taxon_id: NCBITaxon:6645
  taxon_label: Octopus vulgaris
  focus_type: function_assignment
  hypothesis_slug: function-hypothesis-go-0019478
  hypothesis_text: DDO has D-amino acid catabolic process (GO:0019478).
  term_context: '- Term: D-amino acid catabolic process (GO:0019478)

    - Evidence type: IEA

    - Original reference: GO_REF:0000118'
  reference_context: '- GO_REF:0000118'
  source_file: genes/OCTVU/DDO/DDO-ai-review.yaml
  source_selector: existing_annotations[5].function_hypothesis
  source_context_yaml: "term:\n  id: GO:0019478\n  label: D-amino acid catabolic process\n\
    evidence_type: IEA\noriginal_reference_id: GO_REF:0000118"
provider_config:
  timeout: 3600
  max_retries: 3
  parameters:
    allowed_domains: []
    max_iterations: 3
    use_hypotheses: false
    investigation_mode: autonomous
    poll_interval: 30
    timeout: 7200
    save_artifacts: true
    artifact_max_bytes: 5242880
citation_count: 2
artifact_count: 2
artifact_sources:
  openscientist_artifacts_zip: 2
artifacts:
- filename: final_report.html
  path: openscientist_artifacts/final_report.html
  media_type: text/html
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist final report
- filename: final_report.pdf
  path: openscientist_artifacts/final_report.pdf
  media_type: application/pdf
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist final report
---

## Question

# AIGR TreeGrafter Function-Inference Stress Test

You are evaluating one focused gene-function hypothesis for AI Gene Review. The
hypothesis under test was produced by an **automated phylogenetic annotation
pipeline** (TreeGrafter / PANTHER): a query protein was grafted onto a PANTHER
reference tree and a GO term was propagated to it from an ancestral node. Your
job is to judge, **independently and from primary evidence**, whether the query
protein *directly* has the stated function — and, if not, to localize the error.

This is not a general gene overview. Treat any prior curation decision as
intentionally blinded unless it appears in the supplied context. Do **not**
assume the propagated term is correct simply because a homology pipeline emitted
it.

## Target Gene

- **Organism code:** OCTVU
- **Taxon:** Octopus vulgaris (NCBITaxon:6645)
- **Gene directory:** DDO
- **Gene symbol:** DDO
- **UniProt accession:** A0A7E6FSU6

## Focus

- **Focus type:** function_assignment
- **Hypothesis slug:** function-hypothesis-go-0019478
- **Source file:** genes/OCTVU/DDO/DDO-ai-review.yaml
- **Source selector:** existing_annotations[5].function_hypothesis

## Seed Hypothesis (propagated by TreeGrafter/PANTHER)

DDO has D-amino acid catabolic process (GO:0019478).

## Term and Decision Context

- Term: D-amino acid catabolic process (GO:0019478)
- Evidence type: IEA
- Original reference: GO_REF:0000118

## Reference Context

- GO_REF:0000118

## Source Context YAML

```yaml
term:
  id: GO:0019478
  label: D-amino acid catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000118
```

## Research Objective

Decide whether **DDO directly has the stated function**. Automated
phylogenetic propagation fails in three characteristic ways; your report must
actively test for each, because they cannot be detected by the graft alone:

1. **Granularity / family-vs-subfamily.** The propagated term may be the broad
   *family* function while this protein belongs to a more specific (or
   functionally diverged) subfamily. Determine the protein's closest
   **characterized** homolog and its specific activity, and state whether the
   stated term is correct, too general, or names a sibling activity. (Example
   shape: a polyketide synthase module mislabeled with the family-level "fatty
   acid synthase activity".)
2. **Pseudo-enzyme / loss of activity.** The protein may retain the fold but
   have lost catalysis or been co-opted to a structural/non-enzymatic role.
   Check conservation and spacing of the **specific catalytic / metal-binding /
   active-site residues** against characterized active family members; quantify
   any reported residual activity. A conserved fold with degenerate active site
   does **not** support a catalytic MF term.
3. **Within-superfamily mis-placement.** The protein may have been grafted onto
   a structurally related but functionally **distinct** neighboring subfamily of
   a shared fold superfamily (e.g. an oxidoreductase or adenylating-enzyme
   superfamily where several activities share one fold). Identify which
   subfamily the sequence actually belongs to and whether a *different* GO term
   is the correct one.

Where the question is decidable by computation, **actually run the analysis** and
keep it as provenance rather than only reasoning about it:

- **Subfamily / paralog placement:** compare Pfam/InterPro domain architecture,
  orthology, and conservation against characterized members; identify the nearest
  characterized neighbor and the specific function it carries.
- **Active-site test:** align to characterized active members and report whether
  the catalytic/binding residues are present and correctly spaced.
- **Localization / topology** (if a CC term is at issue): hydropathy / predicted
  TM segments, signal/targeting motifs; compare to UniProt features and AlphaFold
  geometry, and to the host organism's actual compartments.

Use resources you can access programmatically (UniProt, InterPro, AlphaFold DB,
sequence computation, public APIs). If a resource is web-only or you cannot run a
check, say so plainly — an inconclusive or "could not run" result is acceptable
and useful. **Never fabricate a result.** Local `*-bioinformatics` analyses, if
they exist in the repo, are intentionally withheld so this report can be compared
against them afterward.

## Required Output

### Executive Judgment

Concise verdict on the seed hypothesis: **supported**, **partially supported /
too general**, **wrong subfamily (mis-placed)**, **pseudo-enzyme / activity
lost**, **unresolved**, or **refuted**. Name which of the three failure modes (if
any) applies, and give the single most decisive piece of evidence.

### Independent Family/Function Assignment

State, from your own analysis, the protein's most likely **specific** molecular
function and the characterized homolog it is based on — independent of the
propagated term. Give the GO term you would assign and its granularity relative
to the seed term (same / more specific / sibling / different branch).

### Evidence Matrix

One row per evidence item: Citation (PMID preferred) · Evidence type (direct
assay, mutant phenotype, structural/evolutionary, computational,
review/database) · Supports / refutes / qualifies / competing · Claim tested ·
Key finding · Organism/assay context · Confidence and limitations.

### Active-Site / Placement Analysis

Report the computed residue-conservation and/or subfamily-placement result
(table or values), with the code/values as provenance if the provider supports
artifacts. State explicitly whether catalytic residues are intact.

### GO Curation Implications

State the likely curation action as a lead requiring curator verification:
retain / generalize / make-more-specific / replace-with-sibling-term / remove /
treat-as-non-core. Avoid "protein binding" as a final recommendation.

### Conflicts, Knowledge Gaps, Discriminating Tests

Note conflicting evidence and alternatives (paralog confusion, organism-specific
differences, isoform effects, database carry-over), explicit uncertainties that
matter for curation, and the most efficient assay/analysis to resolve them.

If the provider supports artifacts, save provenance for any analysis you run —
the executed code together with its output — not just a summary. Do not
synthesize a figure implying an analysis you did not run.


## Output

# AIGR TreeGrafter Function-Inference Stress Test — Final Report

**Target:** *Octopus vulgaris* DDO (UniProt **A0A7E6FSU6**, OXDD_OCTVU)
**Seed hypothesis (TreeGrafter/PANTHER, IEA, GO_REF:0000118):** DDO has **D-amino acid catabolic process (GO:0019478)**
**Focus:** function_assignment · `existing_annotations[5].function_hypothesis`

---

## Summary

The TreeGrafter/PANTHER pipeline propagated the term **GO:0019478 (D-amino acid catabolic process)** to *Octopus vulgaris* DDO (A0A7E6FSU6). Independent, primary-evidence analysis **confirms this assignment is correct**. The query protein is a genuine, catalytically competent **D-aspartate oxidase (EC 1.4.3.1)** — a peroxisomal FAD-dependent flavoenzyme that oxidatively deaminates the acidic D-amino acids D-aspartate (and D-glutamate/NMDA) to the corresponding 2-oxo acid, ammonia, and hydrogen peroxide. This reaction is, by definition, a D-amino acid catabolic process, so the propagated biological-process term is accurate.

Critically, **none of the three characteristic automated-propagation failure modes apply.** (1) On *granularity*, the protein belongs to the correct subfamily — its closest characterized homolog is human D-aspartate oxidase (DDO, Q99489) at 41.4% identity, not the broad-specificity D-amino acid oxidase (DAAO) at ~36%. (2) On *pseudo-enzyme* status, the specific catalytic, substrate-selectivity, cofactor-binding, and targeting residues are all present and correctly spaced in both sequence and the AlphaFold model — the enzyme is active, not a degenerate fold. (3) On *within-superfamily mis-placement*, the sequence sits squarely in the acidic-D-amino-acid-oxidase clade, confirmed by the diagnostic acidic-substrate selectivity arginine R234.

The single most decisive piece of evidence is the intact, physically assembled active site: in the high-confidence AlphaFold model (mean pLDDT 95.3), the catalytic Arg275, selectivity Arg234, and active-site Tyr220 cluster within ~5–8 Å of one another — the geometric signature of a functional acidic-D-amino-acid oxidase — while octopus D-aspartate oxidase is an *experimentally established* enzyme historically used as a specific analytical reagent to quantify D-aspartate ([PMID: 8446003](https://pubmed.ncbi.nlm.nih.gov/8446003/)). The recommended curation action is to **retain** GO:0019478, optionally **making it more specific** by adding the molecular-function term **GO:0008445 (D-aspartate oxidase activity)**. This case is a clean **true-positive** for the TreeGrafter pipeline.

---

## Executive Judgment

**Verdict: SUPPORTED.** The seed hypothesis holds. None of the three failure modes the stress test probes for are present:

| Failure mode | Test applied | Result |
|---|---|---|
| (1) Granularity / wrong subfamily | Closest characterized homolog + diagnostic residue | Closest = human DDO (41.4%); selectivity R234 present → **correct subfamily** |
| (2) Pseudo-enzyme / lost activity | Catalytic/cofactor residue conservation & spacing (sequence + AlphaFold) | All residues intact, pocket assembled → **active enzyme** |
| (3) Within-superfamily mis-placement | DDO vs DAAO vs yeast panel; selectivity Arg | Sits in DDO clade; BP term correct either way → **not mis-placed** |

**Single most decisive piece of evidence:** the intact, correctly-spaced catalytic cluster in the AlphaFold model (R275–R234 = 5.2 Å; R275–Y220 = 5.4 Å), combined with the experimental precedent that octopus D-aspartate oxidase is a real, active enzyme ([PMID: 8446003](https://pubmed.ncbi.nlm.nih.gov/8446003/)).

---

## Independent Family / Function Assignment

Independent of the propagated term, my own analysis assigns:

- **Specific molecular function:** **D-aspartate oxidase activity** (EC 1.4.3.1) — FAD-dependent oxidative deamination of acidic D-amino acids (D-aspartate, D-glutamate/NMDA).
- **Characterized homolog this is based on:** **human DDO (Q99489)**, the nearest characterized neighbor at 41.4% pairwise identity.
- **GO term I would assign:**
  - Molecular function: **GO:0008445 (D-aspartate oxidase activity)** — *more specific* than, and the enzymatic basis for, the seed term.
  - Biological process: **GO:0019478 (D-amino acid catabolic process)** — *same branch as the seed term*; correct as propagated.

**Granularity relative to the seed term:** the seed BP term is **correct (same branch)**; the optional MF addition (GO:0008445) is **more specific**. No sibling or different-branch reassignment is warranted.

---

## Key Findings

### Finding 1 — A0A7E6FSU6 is a bona-fide D-aspartate oxidase with intact catalytic machinery

UniProt curates A0A7E6FSU6 (OXDD_OCTVU) with the recommended name **D-aspartate oxidase, EC 1.4.3.1**. Its domain architecture is exactly what this enzyme requires: **Pfam PF01266 (DAO)**, **InterPro IPR023209 (DAO)** plus **IPR006181 (D-amino acid oxidase conserved site)** with a positive **PROSITE PS00677** match, and **PANTHER PTHR11530**. The entry also carries the UniProt keyword **"Direct protein sequencing"** — the protein was physically isolated and sequenced, strong evidence that this is a genuinely expressed gene product and not a pseudogene or prediction artifact.

A pairwise global alignment over the 336-residue protein places it closest to the **D-aspartate oxidase** subfamily rather than the generic DAAO subfamily:

| Characterized homolog | Pairwise % identity |
|---|---|
| Human **DDO** (Q99489) | **41.4%** (top hit) |
| Human DAAO | 36.3% |
| Pig DAAO | 35.6% |

The specific catalytic and substrate-recognition residues are conserved and correctly positioned (full table in *Active-Site / Placement Analysis* below). The catalytic arginine (human DDO R278 / pig DAAO R283) maps to octopus **R275**; the acidic-substrate selectivity arginine (human DDO R237) maps to **R234**; the active-site tyrosine (pig DAAO Y228) maps to **Y220**; the N-terminal FAD Rossmann fingerprint (GxGxxG) is present as **G8-AGVVGL**; and the C-terminal peroxisomal targeting signal (PTS1) is present as **SKL**. The one non-conserved basic position (human DDO R216 → octopus **Y213**) is distal to the active site and does not affect catalysis. The principal selectivity arginine (R234) — the residue that distinguishes DDO from DAAO by anchoring the side-chain carboxylate of D-aspartate — is fully intact.

### Finding 2 — GO:0019478 is correctly propagated; it could be made more specific

D-aspartate oxidase (EC 1.4.3.1) oxidatively deaminates acidic D-amino acids (D-Asp, D-Glu/NMDA) to the 2-oxo acid + NH₃ + H₂O₂ — by definition a **D-amino acid catabolic process (GO:0019478)**. The octopus is an *established natural source* of this enzyme: **"Octopus D-aspartate oxidase" is used as a specific analytical reagent to quantify D-aspartate** ([PMID: 8446003](https://pubmed.ncbi.nlm.nih.gov/8446003/)), and free D-Asp occurs specifically in cephalopod (*Octopus vulgaris*, *Loligo*, *Sepia*) nervous tissue. There is thus independent biochemical precedent that the octopus genome encodes a catalytically active D-aspartate oxidase, and the sequence/active-site analysis confirms A0A7E6FSU6 is that enzyme. The matching molecular-function term **GO:0008445 (D-aspartate oxidase activity)** is the specific activity underlying the propagated BP term.

> *Verbatim support ([PMID: 8446003](https://pubmed.ncbi.nlm.nih.gov/8446003/)):* "D-Asp was discovered using specific methods that employ **Octopus D-aspartate oxidase** and hog kidney D-amino acid oxidase to measure D-Asp levels."

### Finding 3 — AlphaFold geometry confirms an assembled, intact active site

The AlphaFold DB model **AF-A0A7E6FSU6-F1 (v6, mean pLDDT 95.3)** is high-confidence. The three key residues cluster tightly in three dimensions, forming a compact substrate-binding/catalytic pocket:

| Residue pair | Distance | pLDDT |
|---|---|---|
| Catalytic R275 – selectivity R234 | 5.2 Å | 97 / 94 |
| Catalytic R275 – active-site Y220 | 5.4 Å | 97 / 97 |
| Selectivity R234 – active-site Y220 | 7.6 Å | 94 / 97 |
| Non-conserved Y213 – R275 | 21.5 Å | distal |

Two arginines positioned ~5 Å apart is exactly the arrangement expected for anchoring **both** carboxylate groups of D-aspartate — the structural signature of the acidic-amino-acid oxidase (DDO), not the broad-specificity DAAO. The single non-conserved position (Y213, equivalent to human DDO R216) sits **16–21 Å from the catalytic cluster**, i.e. outside the active site, so its substitution is mechanistically irrelevant. The C-terminal **PTS1 (…S334-K335-L336)** is on a solvent-exposed, lower-pLDDT (82–88) terminus — the appropriate context for Pex5 recognition and peroxisomal import. The N-terminal FAD Rossmann motif centroid lies ~17 Å from the catalytic arginine, consistent with canonical DAO-fold geometry.

### Finding 4 — Subfamily placement across a 9-homolog panel; BP term robust to DDO/DAAO ambiguity

Benchmarking against nine characterized homologs reinforces the DDO assignment:

| Homolog | % identity to octopus |
|---|---|
| Human **DDO** | **41.4%** (best overall) |
| Rat DDO | 37.8% |
| Mouse DAAO | 37.8% |
| Mouse DDO | 36.6% |
| Human DAAO | 36.3% |
| Rat DAAO | 36.3% |
| Pig DAAO | 35.6% |
| Bovine DDO | 32.4% |
| Yeast RgDAAO | 23.8% |
| **Mean DDOs** | **37.1%** |
| **Mean DAAOs** | **33.9%** |

The single best match is human D-aspartate oxidase, and the mean identity to DDOs (37.1%) exceeds that to DAAOs (33.9%). At invertebrate-to-vertebrate evolutionary distance, global identity alone does not cleanly separate DDO from DAAO (the best DAAO, mouse, reaches 37.8%). The *decisive* subfamily feature is therefore the conserved **acidic-substrate selectivity arginine R234** (= human DDO R237), reinforced by UniProt's curated naming and the literature reagent use of octopus D-aspartate oxidase. Crucially, **the propagated BP term (GO:0019478) is robust to the residual DDO/DAAO ambiguity**: both DDO and DAAO catabolize D-amino acids, so the seed term is correct either way; the distinction only affects the optional, more-specific MF term (GO:0008445 vs GO:0003884).

---

## Mechanistic Model / Interpretation

The enzyme is a peroxisomal FAD-dependent oxidase operating on acidic D-amino acids:

```
   D-aspartate  +  O2  +  H2O
          │
          ▼   [ FAD-dependent oxidative deamination ]
   oxaloacetate  +  NH3  +  H2O2
```

Structural logic of the active site (AlphaFold AF-A0A7E6FSU6-F1):

```
        FAD (Rossmann, G8-AGVVGL)
              │  ~17 Å
              ▼
   ┌───────────────────────────────┐
   │   D-aspartate binding pocket   │
   │                                │
   │   R275 (catalytic)             │
   │     │5.2 Å        │5.4 Å       │
   │   R234 (selectivity)  Y220     │
   │        └──7.6 Å──┘             │
   └───────────────────────────────┘
              ▲
   Y213 (non-conserved, 16–21 Å away — outside pocket, irrelevant)

   C-terminus: …S-K-L (PTS1) → Pex5 → peroxisome
```

The two arginines ~5 Å apart form a dual-carboxylate clamp that selects for **acidic** D-amino acids (D-Asp, D-Glu/NMDA), distinguishing this DDO subfamily from the broad-specificity DAAO subfamily, which lacks the second selectivity arginine. The FAD cofactor accepts the hydride during oxidative deamination and is re-oxidized by O₂, generating H₂O₂. The PTS1 (SKL) tripeptide targets the enzyme to the peroxisome, the canonical compartment for this reaction. This is internally consistent biochemistry end to end: a correct fold, a correctly assembled and correctly specific active site, the correct cofactor-binding motif, and the correct subcellular targeting signal all point to a single coherent function.

Biologically, this fits the known neurochemistry of cephalopods, where free D-aspartate accumulates in nervous tissue and a dedicated D-aspartate oxidase provides the catabolic counterpart. The net conclusion is that TreeGrafter got this one right; the case serves as a valuable **true-positive control** for the AIGR stress test — a propagated IEA term that withstands independent primary-evidence scrutiny.

---

## Evidence Base

| # | Citation | Evidence type | Call | Claim tested | Key finding | Context | Confidence / limits |
|---|---|---|---|---|---|---|---|
| 1 | UniProt A0A7E6FSU6 (OXDD_OCTVU) | review/database | **Supports** | Identity/annotation | RecName D-aspartate oxidase, EC 1.4.3.1; PF01266, IPR023209+IPR006181 (PS00677 match), PTHR11530; keyword "Direct protein sequencing" | *O. vulgaris* | High; DB annotation backed by direct sequencing |
| 2 | Global alignment (this work) | computational | **Supports** | Subfamily placement | 41.4% id to human DDO vs ~36% to DAAO → closest neighbor is D-aspartate oxidase | in silico | High for "closest = DDO"; moderate because %id doesn't fully separate DDO/DAAO at this distance |
| 3 | Residue mapping (this work) | structural/evolutionary | **Supports** | Active site intact | Catalytic Arg→R275; selectivity Arg→R234; active Tyr→Y220; FAD GxGxxG; PTS1 SKL all conserved | in silico | High; sequence-level, not crystallographic |
| 4 | [PMID: 8446003](https://pubmed.ncbi.nlm.nih.gov/8446003/) — *Occurrence of free D-aspartic acid in the circumsoesophageal ganglia of Aplysia fasciata* | direct assay / reagent use | **Supports** | Enzyme is real & active | "Octopus D-aspartate oxidase" used as a specific reagent to quantify D-Asp | mollusc neurochemistry | High that octopus DDO is an established active reagent; indirect link to this exact accession |
| 5 | [PMID: 24237903](https://pubmed.ncbi.nlm.nih.gov/24237903/) — *Degradation of human DAAO and pLG72* | review | **Qualifies** | Family biochemistry/compartment | hDAAO (EC 1.4.3.3) is a peroxisomal flavoenzyme in D-serine catabolism | human brain/U87 | Moderate; concerns the sibling DAAO, provides contrast for subfamily distinction |
| 6 | AlphaFold AF-A0A7E6FSU6-F1 v6 | structural/computational | **Supports** | Active site assembled | R275/R234/Y220 within 5–8 Å (pLDDT 94–97); Y213 16–21 Å away; PTS1 SKL exposed | in silico (pLDDT 95.3) | High-confidence model; predicted not experimental structure |

**How the two literature papers bear on the findings.** [PMID: 8446003](https://pubmed.ncbi.nlm.nih.gov/8446003/) is the key positive anchor: it establishes that an *active* octopus D-aspartate oxidase exists and is reliable enough to be used as a specific analytical reagent — directly corroborating that the octopus DDO gene product carries genuine catalytic activity. [PMID: 24237903](https://pubmed.ncbi.nlm.nih.gov/24237903/) describes the sibling enzyme human DAAO as a peroxisomal flavoenzyme central to brain D-serine catabolism; it supports the family-level mechanism and compartment while underscoring the DDO-vs-DAAO distinction that the active-site analysis resolves.

---

## Active-Site / Placement Analysis (computed)

**Catalytic residues: INTACT.** Pairwise global alignment of A0A7E6FSU6 against characterized members, with residues mapped from reference numbering to octopus positions:

| Reference position | Role | Octopus residue | Conserved? | AlphaFold position |
|---|---|---|---|---|
| human DDO R278 / pig DAAO R283 | catalytic Arg (binds α-carboxylate) | **R275** | Yes | Core of pocket (pLDDT 97) |
| human DDO R237 | acidic-substrate selectivity Arg (DDO diagnostic) | **R234** | Yes | 5.2 Å from R275 (pLDDT 94) |
| pig DAAO Y228 | active-site Tyr | **Y220** | Yes | 5.4 Å from R275 (pLDDT 97) |
| N-term FAD Rossmann GxGxxG | FAD binding | **G8-AGVVGL** | Yes | ~17 Å from catalytic Arg |
| human DDO R216 | second DDO basic residue | **Y213** | No (Arg→Tyr) | 16–21 Å from pocket (distal, irrelevant) |
| C-term PTS1 | peroxisomal targeting | **S334-K335-L336 (SKL)** | Yes | Solvent-exposed C-terminus (pLDDT 82–88) |

**Interpretation.** Identity: octopus vs human DDO **41.4%**, vs human DAAO 36.3%, vs pig DAAO 35.6% (~331–333 aligned columns each). **Catalytic residues are intact → not a pseudo-enzyme; subfamily is D-aspartate oxidase → not mis-placed.** The structural confirmation from AlphaFold (mean pLDDT 95.3) shows the catalytic/substrate residues clustering into a compact, high-confidence active site (R275–R234 = 5.2 Å, R275–Y220 = 5.4 Å, R234–Y220 = 7.6 Å, all pLDDT 94–97), confirming the pocket is physically assembled. The single non-conserved position (Y213 = human DDO R216) lies 16–21 Å from the catalytic cluster, so the substitution flagged in the sequence analysis is **structurally peripheral and functionally irrelevant**. The sequence therefore belongs to the **acidic-D-amino-acid-oxidase (DDO) subfamily** of the DAO flavoprotein fold, with the conserved selectivity arginine R234 as the decisive discriminator.

---

## GO Curation Implications

**Recommended curation action (lead requiring curator verification):**

- **GO:0019478 (D-amino acid catabolic process), BP — RETAIN.** The propagated IEA term is correct and well-supported by independent primary evidence. The IEA/GO_REF:0000118 propagation is accurate here and can be upgraded with the sequence- and structure-based evidence above.
- **Optionally MAKE-MORE-SPECIFIC** by adding the molecular-function term **GO:0008445 (D-aspartate oxidase activity)** / EC 1.4.3.1, which the sequence and active-site evidence directly support.
- Do **not** remove, generalize, replace with a sibling term, treat as non-core, or fall back to "protein binding." The annotation is core and accurate.

This is a **true-positive** TreeGrafter propagation and a useful positive control for the AIGR pipeline.

---

## Limitations and Knowledge Gaps

1. **No direct enzymatic assay on this exact accession.** Catalytic competence is inferred from sequence conservation, AlphaFold geometry, and the general precedent that octopus D-aspartate oxidase is an active, reagent-grade enzyme ([PMID: 8446003](https://pubmed.ncbi.nlm.nih.gov/8446003/)). A kinetic assay on recombinant A0A7E6FSU6 would convert high-confidence inference into direct evidence.
2. **DDO vs DAAO not cleanly separable by global identity.** At invertebrate-to-vertebrate distance, the best DAAO homolog (mouse, 37.8%) is close to the DDO mean (37.1%). The DDO call rests principally on the single diagnostic selectivity arginine (R234) plus curated naming — a narrow structural feature. Residual DAAO-like activity on neutral/basic D-amino acids cannot be excluded without substrate-profiling. Importantly, this ambiguity does **not** affect the BP term under test.
3. **AlphaFold is a model, not an experimental structure.** The pocket geometry (R275–R234 = 5.2 Å, etc.) is a high-confidence prediction (pLDDT 95.3), but no crystal or cryo-EM structure of this protein exists to confirm it.
4. **Accession-to-literature link is indirect.** The historical reagent "octopus D-aspartate oxidase" predates this genome-derived accession; their identity is highly plausible but not formally proven.
5. **GO_REF:0000118 / IEA provenance** was taken as given; the reference-tree graft itself was not re-run here.

---

## Proposed Follow-up Experiments / Actions

1. **Recombinant kinetic assay (most decisive).** Express A0A7E6FSU6 in *E. coli* or yeast and measure activity on D-aspartate and D-glutamate/NMDA (expected DDO substrates) versus neutral/basic D-amino acids (D-serine, D-alanine, D-proline — DAAO substrates). A high D-Asp/D-Ser activity ratio confirms strict DDO identity and would justify locking in GO:0008445.
2. **Substrate-selectivity mutagenesis.** Mutate R234→Y (mimicking the DAAO-like loss of the second selectivity arginine) and test whether acidic-substrate preference is abolished — a direct functional validation that R234 is the DDO determinant.
3. **Peroxisomal localization check.** Confirm the PTS1 (SKL) functions by expressing a GFP-fusion in a cephalopod or heterologous cell line and verifying peroxisomal import, closing the loop on the compartment.
4. **Experimental structure.** A crystal structure with a bound substrate/analog (e.g., D-aspartate or a malate/tartrate mimic) would verify the AlphaFold-predicted dual-arginine clamp.
5. **Curatorial action.** Flag the annotation as a verified true-positive and, pending or in lieu of assay, add GO:0008445 as an ISS/IEA molecular-function term with the active-site evidence as the justification.

---

*Report generated from a 3-iteration autonomous investigation. Findings F001–F004 and literature PMIDs 8446003 and 24237903 as recorded in the knowledge state.*


## Artifacts

- [OpenScientist final report](openscientist_artifacts/final_report.html)
- [OpenScientist final report](openscientist_artifacts/final_report.pdf)